Ironwood Pharmaceuticals Inc stock is traded at $4.03, with a volume of 4,995,553. It is up +6.90% in the last 24 hours and up +10.41% over the past month. Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Previous Close:
$3.77
Open:
$4.30
24h Volume:
4,995,553
Relative Volume:
2.61
Market Cap:
$665.92M
Revenue:
$361.51M
Net Income/Loss:
$102.18M
P/E Ratio:
6.75
EPS:
$0.5974
Net Cash Flow:
$112.21M
1W Performance:
+11.33%
1M Performance:
+10.41%
6M Performance:
-13.70%
1Y Performance:
+95.63%
1-Day Range:
$3.84$4.41
1-Week Range:
$3.40$4.41
52-Week Range:
$1.88$5.78
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Name
Ironwood Pharmaceuticals IncSector
HealthcarePhone
617-621-7722Address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS